John Drayton Wise - Feb 5, 2025 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Commercial Officer
Signature
/s/ John Drayton Wise, by Michael A. Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
Feb 5, 2025
Transactions value $
-$640,708
Form type
4
Date filed
2/7/2025, 05:11 PM
Previous filing
Jan 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Award $0 +15.4K +12.24% $0.00 141K Feb 5, 2025 Direct F1
transaction INSM Common Stock Sale -$640K -7.91K -5.61% $80.90 133K Feb 6, 2025 Direct F2, F3
transaction INSM Common Stock Sale -$789 -10 -0.01% $78.91 133K Feb 7, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.
F2 Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.
F3 This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.